Records View

Neurological pupil index and neuron-specific enolase for prediction of outcomes after out-of-hospital cardiac arrest

Status Approved

  • First Submitted Date

    2019/08/21

  • Registered Date

    2019/08/21

  • Last Updated Date

    2019/08/21

CRIS Required

WHO ICTRP (International Clinical Trial Registry Platform) Required

  • 1. Background

    Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
    CRIS
    Registration Number
    KCT0004229
    Unique Protocol ID B-1905/538-305
    Public/Brief Title Neurological pupil index and neuron-specific enolase for prediction of outcomes after out-of-hospital cardiac arrest
    Scientific Title Neurological pupil index and neuron-specific enolase for prediction of outcomes after out-of-hospital cardiac arrest
    Acronym
    MFDS Regulated Study No
    IND/IDE Protocol No
    Registered at Other Registry No
    Healthcare Benefit Approval Status Not applicable
  • 2. Institutional Review Board / Ethics Committee

    Institutional Review Board Information
    Board Approval Status Submitted approval
    Board Approval Number B-1905/538-305
    Approval Date 2019-05-27
    Institutional Review Board Name Seoul National University Bundang Hospital Institutional Review Board
    Institutional Review Board Address 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do
    Institutional Review Board Telephone 031-787-8801
    Data Monitoring Committee No
  • 3. Contact Details

    Contact Details Information - Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Contact Person for Updating Information의 Name, Title, Email, Telephone, Cellular Phone, Affiliation, Address
    Contact Person for Principal Investigator / Scientific Queries
    Name Dong Keon Lee
    Title D.K Lee
    Telephone +82-31-787-3036
    Affiliation Seoul National University Bundang Hospital
    Address 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do
    Contact Person for Public Queries
    Name Haechul Yang
    Title H.C Yang
    Telephone +82-2-787-3031
    Affiliation Seoul National University Bundang Hospital
    Address 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do
    Contact Person for Updating Information
    Name Haechul Yang
    Title H.C Yang
    Telephone +82-2-787-3031
    Affiliation Seoul National University Bundang Hospital
    Address 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do
  • 4. Status

    Status Information - Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt
    Study Site Single
    Overall Recruitment Status Recruiting
    Date of First Enrollment 2019-08-21 Actual
    Target Number of Participant 293
    Primary Completion Date 2020-12-31 , Anticipated
    Study Completion Date 2021-05-26 , Anticipated
    Recruitment Status by Participating Study Site 1
    Name of Study Hanyang University Seoul Hospital
    Recruitment Status Recruiting
    Date of First Enrollment 2019-08-21 ,
  • 5. Source of Monetary / Material Support

    Source of Monetary / Material Support Information - Organization Name, Organization Type, Project ID
    1. Source of Monetary/Material Support
    Organization Name Seoul National University Bundang Hospital
    Organization Type Medical Institute
    Project ID B-1905-538-305
  • 6. Sponsor Organization

    Sponsor Organization Information - Organization Name, Organization Type
    1. Sponsor Organization
    Organization Name Seoul National University Bundang Hospital
    Organization Type Medical Institute
  • 7. Study Summary

    Study Summary Information
    Lay Summary
    purpose of the research
    -Use the Neurosurgical Motion Index (NPi) and neuron-specific Nolase (NSE).
    
    Background of the study
    Predicting the patient's prognosis is important for the efficient use of limited medical resources and for planning and directing the patient's treatment. Not There is no single way to accurately measure the prognosis of cardiac arrest patients.
    An integrated approach is essential.
    
    Hypothesis of research
    Prognosis of cardiac arrest patients can be predicted using pupillometry and NSE.
  • 8. Study Design

    Study Design Information - Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description
    Study Type Interventional Study
    Study Purpose
    Diagnosis
    Phase Not applicable
    Intervention Model Single Group  
    Blinding/Masking Open
    Allocation Not Applicable
    Intervention Type Medical Device  
    Intervention Description
    -Instrument for measuring pupillary response to light stimuli
    -Scan patient's information-> Photostimulation for several seconds according to instructions or protocol and pupil measurement using infrared camera-> Upload patient data to chart
    -From the patient confirmation to the data input, the machine can objectively evaluate the pupillary response regardless of the examiner and can accurately measure changes up to 0.05mm. Reduces human error in patient identification and records.
    -Pupil size, percentage constriction, latency, constriction velocity, dilation velocity, etc. are measured and all these values are substituted into the integrated algorithm to obtain NPi scores between 0 and 5.
    Number of Arms 1
    Arm 1

    Arm Label

    NeurOptics® NPi-200 pupillometer

    Target Number of Participant

    293

    Arm Type

    Experimental

    Arm Description

    -If cardiopulmonary resuscitation is performed using the 'NeurOptics® NPi-200 pupillometer' machine for the cardiac arrest patients who visited the emergency room, the pupillary response is measured every day for three days after the spontaneous circulation recovery.
  • 9. Subject Eligibility

    Subject Eligibility Information
    Condition(s)/Problem(s) * (I00-I99)Diseases of the circulatory system 
       (I46.9)Cardiac arrest, unspecified 

    Out-of-Hospital Cardiac Arrest
    Rare Disease No
    Inclusion Criteria

    Gender

    Both

    Age

    18Year~No Limit

    Description

    Out-of-hospital cardiac arrest patients 18 years and older
    Exclusion Criteria
    Terminal illness
    traumatic patient
    CPC 3-5 before cardiac arrest
    Healthy Volunteers
  • 10. Outcome Measure(s)

    Outcome Measure(s) Information - Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint
    Type of Primary Outcome Not applicable
    Primary Outcome(s) 1
    Outcome
    Pupil size
    Timepoint
    During cardiopulmonary resuscitation, immediately after spontaneous circulation recovery, every 12 hours after spontaneous circulation recovery (up to 72 hours)
    Primary Outcome(s) 2
    Outcome
    reaction rate
    Timepoint
    During cardiopulmonary resuscitation, immediately after spontaneous circulation recovery, every 12 hours after spontaneous circulation recovery (up to 72 hours)
    Primary Outcome(s) 3
    Outcome
    velocity
    Timepoint
    During cardiopulmonary resuscitation, immediately after spontaneous circulation recovery, every 12 hours after spontaneous circulation recovery (up to 72 hours)
    Primary Outcome(s) 4
    Outcome
    velocity velocity
    Timepoint
    During cardiopulmonary resuscitation, immediately after spontaneous circulation recovery, every 12 hours after spontaneous circulation recovery (up to 72 hours)
    Primary Outcome(s) 5
    Outcome
    maximum contraction velocity
    Timepoint
    During cardiopulmonary resuscitation, immediately after spontaneous circulation recovery, every 12 hours after spontaneous circulation recovery (up to 72 hours)
    Secondary Outcome(s) 1
    Outcome
    neuron-specific enolase
    Timepoint
    Immediately after spontaneous circulation recovery, every 12 hours after spontaneous circulation recovery (up to 72 hours)
  • 11. Study Results and Publication

    Study Results and Publication Information - Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary
    Result Registered No
  • 12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)

    Sharing of Study Data Information - Sharing Statement, Time of Sharing, Way of Sharing
    Sharing Statement No
화면 최상단으로 이동

TOP

BOTTOM

화면 최하단으로 이동